IBOV 168,498.45 ▲ 1.39% IPC MEX 71,393.57 ▲ 0.43% MERVAL 2,848,945 — — USD/BRL5.49▼ 0.24% USD/MXN18.57▼ 0.33% USD/CLP971.23▼ 0.55% USD/COP3,238▼ 0.08% USD/PEN3.44▼ 0.08% USD/ARS1,545▼ 0.03% USD/UYU 40.31 — 0.00% USD/PYG 6,358 — 0.00% USD/BOB 11.81 — 0.00% USD/DOP60.63▲ 0.07% USD/CRC 448.27 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.88 — 0.00% USD/NIO 36.62 — 0.00% USD/VES895.29▼ 0.13% USD/PAB1.00— 0.00% USD/BZD2.00— 0.00% USD/JMD157.83— 0.00% USD/TTD6.72— 0.00% EUR/BRL6.14▲ 0.26% BRENT 94.91 ▼ 3.47% WTI 88.36 ▼ 2.72% IRON ORE 161.91 — — COPPER 6.33 ▲ 1.79% GOLD 4,118 ▲ 1.06% SILVER 52.72 ▲ 1.76% SOY 1,195 ▲ 0.46% CORN 443.00 ▲ 0.34% WHEAT 588.50 ▼ 0.47% COFFEE 277.45 ▼ 0.91% SUGAR 18.26 ▲ 0.11% ORANGE JUICE 130.55 ▲ 1.63% COTTON 79.72 ▲ 0.77% COCOA 5,216 ▲ 1.18% BEEF 214.05 ▼ 0.16% CATTLE 322.33 ▼ 0.84% LITHIUM 60.91 ▲ 1.21% PETR4 45.36 — 0.00% VALE3 64.04 — 0.00% ITUB4 40.53 — 0.00% BBDC4 14.20 — 0.00% ABEV3 15.48 — 0.00% BBAS3 17.13 — 0.00% B3SA3 14.39 — 0.00% WEGE3 48.19 — 0.00% PRIO3 60.48 — 0.00% SUZB3 53.40 ▲ 2.12% RENT3 30.29 — 0.00% AZZA3 14.76 ▲ 4.98% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.40 ▲ 0.42% GMAT3 3.80 — 0.00% PSSA3 44.35 ▲ 1.46% CVCB3 0.84 ▲ 2.44% POSI3 3.09 ▼ 0.64% SLCE3 16.61 ▲ 1.59% NATU3 5.17 — 0.00% BRKM5 3.20 — 0.00% RANI3 8.53 ▲ 0.83% CSNA3 4.41 — 0.00% IBOV 168,498.45 ▲ 1.39% IPC MEX 71,393.57 ▲ 0.43% MERVAL 2,848,945 — — USD/BRL 5.49 ▼ 0.25% USD/MXN 18.56 ▼ 0.35% USD/CLP 971.23 ▼ 0.55% USD/COP 3,238 ▼ 0.08% USD/PEN 3.44 ▼ 0.08% USD/ARS 1,545 ▼ 0.03% USD/UYU 40.31 — 0.00% USD/PYG 6,358 — 0.00% USD/BOB 11.81 — 0.00% USD/DOP 60.63 ▲ 0.07% USD/CRC 448.27 — 0.00% USD/GTQ 7.64 — 0.00% USD/HNL 26.88 — 0.00% USD/NIO 36.62 — 0.00% USD/VES 895.29 ▼ 0.13% USD/PAB 1.00 — 0.00% USD/BZD 2.00 — 0.00% USD/JMD 157.83 ▲ 2.67% USD/TTD 6.72 ▲ 2.44% EUR/BRL 6.14 ▲ 0.26% BRENT 94.91 ▼ 3.47% WTI 88.36 ▼ 2.72% IRON ORE 161.91 — — COPPER 6.33 ▲ 1.79% GOLD 4,118 ▲ 1.06% SILVER 52.72 ▲ 1.76% SOY 1,195 ▲ 0.46% CORN 443.00 ▲ 0.34% WHEAT 588.50 ▼ 0.47% COFFEE 277.45 ▼ 0.91% SUGAR 18.26 ▲ 0.11% ORANGE JUICE 130.55 ▲ 1.63% COTTON 79.72 ▲ 0.77% COCOA 5,216 ▲ 1.18% BEEF 214.05 ▼ 0.16% CATTLE 322.33 ▼ 0.84% LITHIUM 60.91 ▲ 1.21% PETR4 45.36 — 0.00% VALE3 64.04 — 0.00% ITUB4 40.53 — 0.00% BBDC4 14.20 — 0.00% ABEV3 15.48 — 0.00% BBAS3 17.13 — 0.00% B3SA3 14.39 — 0.00% WEGE3 48.19 — 0.00% PRIO3 60.48 — 0.00% SUZB3 53.40 ▲ 2.12% RENT3 30.29 — 0.00% AZZA3 14.76 ▲ 4.98% CSAN3 2.77 — 0.00% RAIZ4 28.00 ▲ 2.56% PCAR3 2.40 ▲ 0.42% GMAT3 3.80 — 0.00% PSSA3 44.35 ▲ 1.46% CVCB3 0.84 ▲ 2.44% POSI3 3.09 ▼ 0.64% SLCE3 16.61 ▲ 1.59% NATU3 5.17 — 0.00% BRKM5 3.20 — 0.00% RANI3 8.53 ▲ 0.83% CSNA3 4.41 — 0.00%
since 2009
Monday, November 9, 2026

Covid-19 Brazil

China’s Covid-19 Vaccine Could Be Ready for Distribution in 2020

By · · 2 min read

RIO DE JANEIRO, BRAZIL – The Covid-19 vaccine developed by the Chinese National Pharmaceutical Group, state-owned and known as Sinopharm, may be ready for distribution later this year. The announcement was made by Sinopharm CEO Liu Jingzhen in an interview with Chinese state television CCTV.

World Health Organization Executive Director Michael Ryan ruled out the prospect of a vaccine this quickly.
World Health Organization Executive Director Michael Ryan ruled out the prospect of a vaccine this quickly.
RT
Ask Rio Times
17 years of Latin America reporting, on demand.
Open the full Ask Rio Times →

According to Jingzhen, clinical trials began last week in Abu Dhabi, capital of the United Arab Emirates, and are expected to be completed in approximately three months, paving the way for market delivery by the end of 2020.

However, World Health Organization Executive Director Michael Ryan on Wednesday ruled out the prospect of a vaccine this quickly. “The idea that we will have a vaccine in two or three months and suddenly this virus will have passed… I’d love to tell you that, but it’s not realistic,” he said at a press conference.

Race for Vaccine

Another Chinese lab is also in the race for a vaccine against the novel coronavirus. Pharmaceutical Sinovac is developing the Coronavac in partnership with the São Paulo state-owned Butantan Institute and is already conducting trials on volunteers in Brazil. However, according to São Paulo Governor João Doria, doses for general use should only be produced in early 2021.

Another experimental immunizer being tested in Brazil is the AZD1222, developed by Oxford University with pharmaceutical company AstraZeneca. On yet another front, pharmaceutical companies Pfizer and BioNTech are expected to deliver at least 100 million doses of a coronavirus vaccine by the end of the year, but the amount has already been fully purchased by the United States.

The LatAm Brief

One email, every weekday morning. What moved in Latin American markets, politics and expat life.

Yesterday’s subject line: “Trump says deportations "might be too tough"”

Free. We send a confirmation link first — nothing arrives until you click it. Unsubscribe with one click in any edition. If you stop opening us for 30 days we stop sending by ourselves, as we assume the interest is no longer there. See our privacy policy. We never share your email.

Source: Estadão Conteúdo

This article was produced by The Rio Times’ automated AI newsroom. Editorial responsibility: Matthias Camenzind, Publisher and Editor-in-Chief. The Rio Times also runs Ask Rio Times, which answers from 100,000+ of our own articles, the daily Latin America Power Map, and prediction-market odds on elections and markets.. How we use AI · Report an error

The Rio Times · Power Map
See who really holds power in Latin America
Click to open the Power Map →

Brazil runoff date: Sunday, October 25, poll closing times and when results start · Brazil runoff polls: Flávio 51%, Lula 49% · Kalshi and Polymarket odds

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.